Sublingual Sufentanil: an option for pre-hospital pain management in trauma patients

Submitted: 16 August 2023
Accepted: 1 September 2023
Published: 8 September 2023
Abstract Views: 1165
PDF: 549
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Fabbri A, Voza A, Riccardi A, et al. The pain management of trauma patients in the emergency department. J Clin Med. 2023;12:3289. DOI: https://doi.org/10.3390/jcm12093289
Hutchings C, Yadav K, Cheung WJ, et al. A systematic review of sufentanil for the management of adults with acute pain in the emergency department and pre-hospital setting. Am J Emerg Med 2023;70:10-8. DOI: https://doi.org/10.1016/j.ajem.2023.04.020
Blancher M, Maignan M, Clape C, et al. Intranasal sufentanil versus intravenous morphine for acute severe trauma pain: A double-blind randomized non-inferiority study. PLoS Med 2019;16:e1002849. DOI: https://doi.org/10.1371/journal.pmed.1002849
Lemoel F, Contenti J, Cibiera C, et al. Intranasal sufentanil given in the emergency department triage zone for severe acute traumatic pain: a randomized double-blind controlled trial. Intern Emerg Med 2019;14:571-9. DOI: https://doi.org/10.1007/s11739-018-02014-y
Bounes V, Barthelemy R, Diez O, et al. Sufentanil is not superior to morphine for the treatment of acute traumatic pain in an emergency setting: a randomized, double-blind, out-of-hospital trial. Ann Emerg Med 2010;56:509-16. DOI: https://doi.org/10.1016/j.annemergmed.2010.03.020
Sin B, Jeffrey I, Halpern Z, et al. Intranasal Sufentanil versus intravenous morphine for acute pain in the emergency department: a randomized pilot trial. J Emerg Med 2019;56:301-7. DOI: https://doi.org/10.1016/j.jemermed.2018.12.002
Koushik SS, Schwartz RH, Cherkalin D, et al. A review of sublingual Sufentanil tablet (SST) and its utility as an analgesic agent for pain procedures. Curr Pain Headache Rep 2022;26:145-9. DOI: https://doi.org/10.1007/s11916-022-01014-0
Lindemann C, Strube P, Fisahn C, et al. Patient-controlled sublingual sufentanil tablet system versus intravenous opioid analgesia for postoperative pain management after lumbar spinal fusion surgery. Eur Spine J 2023;32:321-8. DOI: https://doi.org/10.1007/s00586-022-07462-x
Angelini A, Parise GM, Cerchiaro M, et al. Sublingual Sufentanil tablet system (SSTS-Zalviso((R))) for postoperative analgesia after orthopedic surgery: a retrospective study. J Clin Med 2022;11:6864. DOI: https://doi.org/10.3390/jcm11226864
Groen JV, Boon SC, Minderhoud MW, et al. Sublingual Sufentanil versus Standard-of-care (patient-controlled analgesia with epidural Ropivacaine/Sufentanil or intravenous morphine) for postoperative pain following pancreatoduodenectomy: a randomized trial. J Pain Res 2022;15:1775-86. DOI: https://doi.org/10.2147/JPR.S363545
Lomangino I, Berni A, Lloret Madrid A, et al. Sublingual Sufentanil in pain management after pulmonary resection: a randomized prospective study. Ann Thorac Surg 2022;113:1867-72. DOI: https://doi.org/10.1016/j.athoracsur.2021.06.063
Hachimi-Idrissi S, Coffey F, Hautz WE, et al. Approaching acute pain in emergency settings: European Society for Emergency Medicine (EUSEM) guidelines-part 1: assessment. Intern Emerg Med 2020;15:1125-39. DOI: https://doi.org/10.1007/s11739-020-02477-y
Sacerdote P, Coluzzi F, Fanelli A. Sublingual sufentanil, a new opportunity for the improvement of postoperative pain management in Italy. Eur Rev Med Pharmacol Sci 2016;20:1411-22.

How to Cite

Pucciarelli, G., Lucenti, E., Andreucci, A., De Iaco, F., Torrano, V., Marinangeli, F., & Sbrana , G. (2023). Sublingual Sufentanil: an option for pre-hospital pain management in trauma patients. Emergency Care Journal, 19(3). https://doi.org/10.4081/ecj.2023.11665